Satoshi Uno

Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH)

Hidehiro Κakizaki, Kyu‐Sung Lee, Osamu Yamamoto et al. · European Urology Focus · 2019 · 69 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus

Hiroshi Hayami, Satoshi Takahashi, Kiyohito Ishikawa et al. · Journal of Infection and Chemotherapy · 2013 · 65 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study

Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe et al. · Expert Opinion on Pharmacotherapy · 2017 · 35 citations · Full text

Pharmacy, Internal Medicine, Pharmacology +17

Long-term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis: 5-year Interim Postmarketing Surveillance Study in Japan (TRUST)

Tsutomu Takeuchi, Naoko Wakasugi, Satoshi Uno et al. · The Journal of Rheumatology · 2020 · 32 citations

Life Sciences, Immunology, Pharmacotherapy +15

Anticholinergic burden in the Japanese elderly population: Use of antimuscarinic medications for overactive bladder patients

Masaki Yoshida, Daisuke Kato, Takuya Nishimura et al. · International Journal of Urology · 2018 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16